MHC Class I Family Proteins Retard Systemic Lupus Erythematosus Autoimmunity and B Cell Lymphomagenesis
暂无分享,去创建一个
J. Bubier | D. Roopenian | T. Sproule | H. Morse | Martin P. Steinbuck | Dong-Mi Shin | C. McPhee | William H. Schott | Lia Avenesyan
[1] D. Roopenian,et al. The Neonatal FcR-Mediated Presentation of Immune-Complexed Antigen Is Associated with Endosomal and Phagosomal pH and Antigen Stability in Macrophages and Dendritic Cells , 2011, The Journal of Immunology.
[2] D. Roopenian,et al. CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice , 2011, Proceedings of the National Academy of Sciences.
[3] Kazuhiko Yamamoto,et al. Faculty Opinions recommendation of Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. , 2010 .
[4] Xiaolei Tang,et al. Inhibition of follicular T helper cells by CD8+ Treg is essential for self tolerance , 2010, Nature.
[5] A. La Cava,et al. CD8+ Tregs in lupus, autoimmunity, and beyond. , 2010, Autoimmunity reviews.
[6] J. Ward,et al. The Histopathologic and Molecular Basis for the Diagnosis of Histiocytic Sarcoma and Histiocyte–Associated Lymphoma of Mice , 2010, Veterinary pathology.
[7] Sung-Hwan Park,et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea , 2010, Clinical Rheumatology.
[8] C. Weyand,et al. Treating autoimmune disease by targeting CD8+ T suppressor cells , 2009, Expert opinion on biological therapy.
[9] C. Gordon,et al. Lupus and cancer , 2009, Lupus.
[10] W. Leonard,et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice , 2009, Proceedings of the National Academy of Sciences.
[11] R. Flavell,et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity , 2008, The Journal of experimental medicine.
[12] L. Chess,et al. Qa-1/HLA-E-restricted regulatory CD8+ T cells and self-nonself discrimination: an essay on peripheral T-cell regulation. , 2008, Human immunology.
[13] Y. Okuno,et al. Are CD8+CD122+ cells regulatory T cells or memory T cells? , 2008, Human immunology.
[14] D. Zillikens,et al. Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita , 2008, Journal of Molecular Medicine.
[15] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[16] J. Andersen,et al. Dependence of antibody-mediated presentation of antigen on FcRn , 2008, Proceedings of the National Academy of Sciences.
[17] A. Lukacher,et al. Generation of Antiviral Major Histocompatibility Complex Class I-Restricted T Cells in the Absence of CD8 Coreceptors , 2008, Journal of Virology.
[18] K. Isobe,et al. Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.
[19] S. Akilesh,et al. FcRn: the neonatal Fc receptor comes of age , 2007, Nature Reviews Immunology.
[20] Hongzhu Liu,et al. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. , 2007, Arthritis and rheumatism.
[21] D. Roopenian,et al. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. , 2005, The Journal of clinical investigation.
[22] L. Benoit,et al. Influence of Xenogeneic β2-Microglobulin on Functional Recognition of H-2Kb by the NK Cell Inhibitory Receptor Ly49C1 , 2005, The Journal of Immunology.
[23] D. Gladman,et al. An international cohort study of cancer in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.
[24] D. Singer,et al. MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice , 2005, Lupus.
[25] Linrong Lu,et al. Qa-1 restriction of CD8+ suppressor T cells. , 2004, The Journal of clinical investigation.
[26] S. Akilesh,et al. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. , 2004, The Journal of clinical investigation.
[27] Andreas Radbruch,et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice , 2004 .
[28] N. Matsumoto,et al. A species-specific determinant on beta2-microglobulin required for Ly49A recognition of its MHC class I ligand. , 2004, International immunology.
[29] V. Cerundolo,et al. Immunoregulatory Role of CD1d in the Hydrocarbon Oil-Induced Model of Lupus Nephritis1 , 2003, The Journal of Immunology.
[30] S. Akilesh,et al. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.
[31] E. Choi,et al. The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs1 , 2003, The Journal of Immunology.
[32] Chad W. Euler,et al. Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers , 2002, Science.
[33] N. Harris,et al. Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.
[34] M. Shlomchik,et al. Deficiency in β2-Microglobulin, But Not CD1, Accelerates Spontaneous Lupus Skin Disease While Inhibiting Nephritis in MRL-Faslpr Mice: An Example of Disease Regulation at the Organ Level1 , 2001, The Journal of Immunology.
[35] D. Kono,et al. The Role of αβ+ T Cells and Homeostatic T Cell Proliferation in Y-Chromosome-Associated Murine Lupus1 , 2001, The Journal of Immunology.
[36] D. Kono,et al. The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. , 2001, Journal of immunology.
[37] P. Marrack,et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. , 2000, Science.
[38] P. Morrissey,et al. Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.
[39] L. Avioli,et al. Hodgkin's disease , 1969, Bone Marrow Transplantation.
[40] K. Lennert,et al. Splenic marginal zone lymphomas of mice. , 1999, The American journal of pathology.
[41] H. Etlinger,et al. the Journal of Immunology , 2006 .
[42] G. Srivastava,et al. Progression of spontaneous lymphomas in SJL mice: monitoring in vivo clonal evolution with molecular markers in sequential splenic samples. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[43] H. Ploegh,et al. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Llano,et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Ikehara,et al. Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW x BXSB)F1 mice. , 1998, Immunobiology.
[46] M. Bevan,et al. CD8 lineage commitment in the absence of CD8. , 1997, Immunity.
[47] Seokmann Hong,et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. , 1997, Immunity.
[48] R. Blankenburg,et al. beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. , 1996, Journal of immunology.
[49] S. Tonegawa,et al. Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human beta 2-microglobulin transgene , 1995, The Journal of experimental medicine.
[50] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[51] N. Ponzio,et al. Influence of T-helper cell specific monoclonal antibody on progressive growth of B-cell lymphomas in SJL/J mice: correlation of acute treatment dosage with tumor dormancy or complete remission in long-term survivors. , 1990, Cancer communications.
[52] E. Chow,et al. Age‐related changes in the morphology and immunophenotype of spontaneous lymphomas of sjl/n mice , 1988, The Journal of pathology.
[53] N. Ponzio,et al. In vivo growth inhibition of Ia+ lymphomas in SJL mice treated with I-As-reactive monoclonal antibody. , 1986, Immunopharmacology.
[54] R. Germain,et al. Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. K. Kumar,et al. Hodgkin's disease. SJL/J murine lymphoma. , 1983, The American journal of pathology.
[56] A. Theofilopoulos,et al. Suppression of transferred BXSB male SLE disease by female spleen cells. , 1982, Journal of immunology.
[57] L. Stanton,et al. On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. , 1982, Nucleic acids research.
[58] D. Lowy,et al. Structure of endogenous murine leukemia virus DNA in mouse genomes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Roths,et al. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. , 1979, Arthritis and rheumatism.
[60] A. Theofilopoulos,et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.
[61] E. Murphy. Sjl/j, a new inbred strain of mouse with a high, early incidence of reticulum-cell neoplasma. Abstr. , 1963 .